Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study” - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: "Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Patients with Type 2 Diabetes - Insights from a Real-World Analysis

  • August 26, 2025

Share

Clinical Scorecard: Erratum: Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Patients with Type 2 Diabetes - Insights from a Real-World Analysis

At a Glance

CategoryDetail
ConditionNot applicable (Erratum regarding authorship and funding corrections)
Key MechanismsNot applicable
Target PopulationNot applicable
Care SettingNot applicable

Key Highlights

  • Correction of hyphenation in author names Benaya Rozen-Zvi and Anat Gafter-Gvili.
  • Correction of author name hyphenation in the Funding section.
  • Original article has been corrected online to reflect these changes.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

            References

            Original Source(s)

            Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

            • August 26, 2025

            Related Content

            Smartwatch calorie accuracy is assessed

            Investigators evaluated energy-expenditure estimates from 4 consumer devices using indirect calorimetry during controlled cycling in Hispanic adults.

            Medical Oddities: Dogs share our mortality markers

            The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

            Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk